EU starts real-time review of Sanofi-GSK coronavirus jab

Sanofi-GSK hope for approval this year after early-stage results showed the vaccine produces a robust immune response.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…